Clinical Trial

PEDİATRİC MİGRAİNE PATİENTS İN FİNDİNGS

Completed
View on ClinicalTrials.gov →
Summary
Migraine is a common neurological disease in the pediatric population. However, studies investigating the clinical symptoms associated with the different phases of migraine attacks (prodrome, aura, postdrome), particularly in childhood and adolescence, remain limited. The aim of this study was to evaluate the clinical symptoms experienced by children with migraine during attack phases (prodrome, aura, postdrome) and to investigate potential differences in these symptoms according to age and gender The first 18 questions assessed sociodemographic variables, including age, sex, body weight, parental characteristics, social status, age at migraine diagnosis and symptoms, knowledge of migraine, family history of migraine, comorbid conditions, and access to healthcare services. The second part of the questionnaire consisted of questions on headache and migraine-related symptoms and clinical characteristics (questions 19-26), migraine treatment (questions 28-34), and postdrome features (questions 35-39). The study examined migraine-related symptoms and clinical characteristics, treatment approaches, and the influence of sex and age group on the stages of migraine. All patients underwent an assessment of headaches within the last three months, along with physical and neurological examinations. The diagnosis of migraine was made according to the ICHD-III criteria.
Trial Details
NCT Number NCT07593287
Lead Sponsor Mersin University
Conditions Migraine, Pediatric Migraine
Enrollment 45 participants
Start Date 2021-04-01
Primary Completion 2021-09-01 (estimated)
Study Completion 2021-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-18